MedTrace Logo

Assessment of Circuit Rebreathing During CPAP Therapy

NCT07062770 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2025-07-14

No results posted yet for this study

Summary

The goal of this research is to better understand how different CPAP mask designs affect airflow and rebreathing of exhaled carbon dioxide (CO₂) during sleep in individuals with obstructive sleep apnea (OSA).

Conditions

  • Obstructive Sleep Apnea (OSA)

Interventions

DEVICE

Continuous positive airway pressure (CPAP)

Subjects will be administered either 0, 5 or 10 cmH2O

OTHER

Mask exhaust port flow

Subjects will be administered varying levels of exhaust flow: 35, 23, 18, 13 and 8 L/s

Sponsors & Collaborators

  • Sleep Res, Inc.

    collaborator UNKNOWN

  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Atqiya Aishah, PhD · Harvard Medical School & Brigham and Women's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-27
Primary Completion
2025-12-01
Completion
2025-12-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07062770 on ClinicalTrials.gov